Singapore
· Delayed Price · Currency is SGD Clearbridge Health Statistics
Total Valuation
Clearbridge Health has a market cap or net worth of SGD 7.44 million. The enterprise value is 14.16 million.
| Market Cap | 7.44M |
| Enterprise Value | 14.16M |
Important Dates
The last earnings date was Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Clearbridge Health has 1.86 billion shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.86B |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 17.30% |
| Owned by Institutions (%) | 0.64% |
| Float | 1.48B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| PB Ratio | 0.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.44 |
| EV / Sales | 1.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.11 |
Financial Position
The company has a current ratio of 0.59, with a Debt / Equity ratio of 0.68.
| Current Ratio | 0.59 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.81 |
| Interest Coverage | -6.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 81,752 |
| Profits Per Employee | -267,777 |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -83.33% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 44.88 |
| Average Volume (20 Days) | 20,710,865 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clearbridge Health had revenue of SGD 9.89 million and -32.40 million in losses. Loss per share was -0.05.
| Revenue | 9.89M |
| Gross Profit | 4.72M |
| Operating Income | -4.68M |
| Pretax Income | -34.88M |
| Net Income | -32.40M |
| EBITDA | -4.38M |
| EBIT | -4.68M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 1.24 million in cash and 6.24 million in debt, giving a net cash position of -5.00 million or -0.00 per share.
| Cash & Cash Equivalents | 1.24M |
| Total Debt | 6.24M |
| Net Cash | -5.00M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 9.24M |
| Book Value Per Share | 0.01 |
| Working Capital | -3.10M |
Cash Flow
In the last 12 months, operating cash flow was -3.07 million and capital expenditures -376,000, giving a free cash flow of -3.45 million.
| Operating Cash Flow | -3.07M |
| Capital Expenditures | -376,000 |
| Free Cash Flow | -3.45M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 47.71% |
| Operating Margin | -47.34% |
| Pretax Margin | -352.62% |
| Profit Margin | n/a |
| EBITDA Margin | -44.32% |
| EBIT Margin | -47.34% |
| FCF Margin | n/a |
Dividends & Yields
Clearbridge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.14% |
| Shareholder Yield | -0.14% |
| Earnings Yield | -1,307.82% |
| FCF Yield | -46.35% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Clearbridge Health has an Altman Z-Score of -6.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.6 |
| Piotroski F-Score | n/a |